Usually, FOXO3a loss of function determines deregulation in cell proliferation and DNA damage accumulation, resulting in tissue disorders and several cancer types development (including breast and prostate cancer, glioblastoma, rhabdomyosarcoma and leukemia).2, 9. Here, FOXO3 is linked to leukemia.